According to Compugen's latest financial reports the company's current EPS (TTM) is -$0.40. In 2022 the company made an earnings per share (EPS) of -$0.40 an increase over its 2021 EPS that were of -$0.40.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.40 | 0% |
2022 | -$0.40 | -0% |
2021 | -$0.40 | 8.11% |
2020 | -$0.37 | -15.91% |
2019 | -$0.44 | 10% |
2018 | -$0.40 | -44.44% |
2017 | -$0.72 | 16.13% |
2016 | -$0.62 | 55% |
2015 | -$0.40 | 73.91% |
2014 | -$0.23 | -36.11% |
2013 | -$0.36 | -5.26% |
2012 | -$0.38 | 8.57% |
2011 | -$0.35 | 59.09% |
2010 | -$0.22 | 69.23% |
2009 | -$0.13 | -70.45% |
2008 | -$0.44 | 4.76% |
2007 | -$0.42 | -10.64% |
2006 | -$0.47 | -6% |
2005 | -$0.50 | -0% |
2004 | -$0.50 | 16.28% |
2003 | -$0.43 | -8.51% |
2002 | -$0.47 | -20.34% |
2001 | -$0.59 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Seagen
SGEN | -$4.01 | 902.50% | ๐บ๐ธ USA |
Genetic Technologies GENE | N/A | N/A | ๐ฆ๐บ Australia |
Teva Pharmaceutical Industries TEVA | -$2.00 | 400.00% | ๐ฎ๐ฑ Israel |
Eterna Therapeutics ERNA | -$5.64 | 1,310.00% | ๐บ๐ธ USA |